Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Johnson & Johnson Vs. AbbVie: The Better Dividend Aristocrat Buy Might Shock You
12:15pm, Friday, 06'th Jan 2023 Seeking Alpha
Johnson & Johnson and AbbVie Inc. historically fall 70% to 80% less than the S&P 500 Index during bear markets since 1985. Click here to find out which is the better dividend aristocrat.
Johnson & Johnson Vs. AbbVie: The Better Dividend Aristocrat Buy Might Shock You
07:15am, Friday, 06'th Jan 2023
2023 is likely to start out weak for stocks, and they could potentially fall 15% to 23% in the coming weeks. Healthcare is one of only two sectors that historically goes up in recessions, and dividend
S&P 500's Best Dividend Aristocrats
08:39pm, Thursday, 05'th Jan 2023 The Motley Fool
Investors looking for stability and payout growth should look closer at Dividend Aristocrat stocks.
The Best S&P 500 Index Funds
05:08pm, Thursday, 05'th Jan 2023 The Motley Fool
Find out which index funds tracking the S&P 500 have the lowest fees, highest assets under management, and most closely track the market.
Long-Term Investors' 9 Favorite Index Funds
04:55pm, Thursday, 05'th Jan 2023 The Motley Fool
Here are the nine best index funds to add to your portfolio for steady, low-cost growth.
Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock
02:00pm, Thursday, 05'th Jan 2023 Zacks Investment Research
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should Vanguard High Dividend Yield ETF (VYM) Be on Your Investing Radar?
11:20am, Thursday, 05'th Jan 2023 Zacks Investment Research
Style Box ETF report for VYM
Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?
11:20am, Thursday, 05'th Jan 2023 Zacks Investment Research
Style Box ETF report for IWX
Johnson & Johnson's Band-Aid and Tylenol company Kenvue files for IPO, moving closer to spin off
11:08am, Thursday, 05'th Jan 2023
Johnson & Johnson (NYSE:JNJ)'s consumer health unit Kenvue has filed to be listed as an independent company on the New York Stock Exchange under the ticker symbol "KVUE." Kenvue, which J&J says has co
Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock
10:32am, Thursday, 05'th Jan 2023
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
5 Top Stocks to Buy to Start the New Year Right
10:30am, Thursday, 05'th Jan 2023 The Motley Fool
This may be the easiest of your New Year's resolutions. And it could pay off big.
J&J spinoff Kenvue files initial public offering
08:13am, Thursday, 05'th Jan 2023
Kenvue Inc. KVUE, , the consumer products unit of Johnson & Johnson JNJ, +1.09% , late Wednesday filed its initial public offering as part of a previously disclosed spinoff plan for the business. Kenv
"Motley Fool Money" 2023 Investing Preview
07:12pm, Wednesday, 04'th Jan 2023 The Motley Fool
Stocks to watch, stocks to avoid, CEOs on the hot seat, and a few reckless predictions.
These were Warren Buffett's 10 best performing stocks held by Berkshire Hathaway in 2022
02:43pm, Wednesday, 04'th Jan 2023
Some of the best performers have been owned by Buffett for decades, like Coca-Cola, while others are new additions to the portfolio, like T-Mobile.
Worried About 2023? Here's a Safer Way to Invest in Stocks This Year
02:37pm, Wednesday, 04'th Jan 2023 The Motley Fool
By holding a broad range of stocks and spreading out your investment over the year, you can minimize your overall risk.
